JP2017181518A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017181518A5 JP2017181518A5 JP2017111070A JP2017111070A JP2017181518A5 JP 2017181518 A5 JP2017181518 A5 JP 2017181518A5 JP 2017111070 A JP2017111070 A JP 2017111070A JP 2017111070 A JP2017111070 A JP 2017111070A JP 2017181518 A5 JP2017181518 A5 JP 2017181518A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- detection reagent
- autoantibody against
- tau
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 20
- 239000000090 biomarker Substances 0.000 claims 12
- 239000003153 chemical reaction reagent Substances 0.000 claims 12
- 238000001514 detection method Methods 0.000 claims 12
- 239000012472 biological sample Substances 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 5
- 238000003776 cleavage reaction Methods 0.000 claims 4
- 239000007857 degradation product Substances 0.000 claims 4
- 230000007017 scission Effects 0.000 claims 4
- 102000013498 tau Proteins Human genes 0.000 claims 4
- 108010026424 tau Proteins Proteins 0.000 claims 4
- 101000891579 Homo sapiens Microtubule-associated protein tau Proteins 0.000 claims 3
- 101100480719 Rattus norvegicus Mapt gene Proteins 0.000 claims 3
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 102000057063 human MAPT Human genes 0.000 claims 3
- 230000000926 neurological effect Effects 0.000 claims 3
- 230000009529 traumatic brain injury Effects 0.000 claims 3
- 208000004051 Chronic Traumatic Encephalopathy Diseases 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 2
- 208000017004 dementia pugilistica Diseases 0.000 claims 2
- 210000002381 plasma Anatomy 0.000 claims 2
- 210000003296 saliva Anatomy 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24212309P | 2009-09-14 | 2009-09-14 | |
| US61/242,123 | 2009-09-14 | ||
| US35450410P | 2010-06-14 | 2010-06-14 | |
| US61/354,504 | 2010-06-14 | ||
| US35577910P | 2010-06-17 | 2010-06-17 | |
| US61/355,779 | 2010-06-17 | ||
| US38015810P | 2010-09-03 | 2010-09-03 | |
| US61/380,158 | 2010-09-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015253708A Division JP2016105097A (ja) | 2009-09-14 | 2015-12-25 | ニューロン損傷診断のためのマイクロｒｎａ、自己抗体およびタンパク質マーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017181518A JP2017181518A (ja) | 2017-10-05 |
| JP2017181518A5 true JP2017181518A5 (enExample) | 2017-11-30 |
| JP6469760B2 JP6469760B2 (ja) | 2019-02-13 |
Family
ID=43733138
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012528991A Active JP5909447B2 (ja) | 2009-09-14 | 2010-09-14 | ニューロン損傷診断のためのマイクロｒｎａ、自己抗体およびタンパク質マーカー |
| JP2015253708A Pending JP2016105097A (ja) | 2009-09-14 | 2015-12-25 | ニューロン損傷診断のためのマイクロｒｎａ、自己抗体およびタンパク質マーカー |
| JP2017111070A Active JP6469760B2 (ja) | 2009-09-14 | 2017-06-05 | ニューロン損傷診断のためのマイクロｒｎａ、自己抗体およびタンパク質マーカー |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012528991A Active JP5909447B2 (ja) | 2009-09-14 | 2010-09-14 | ニューロン損傷診断のためのマイクロｒｎａ、自己抗体およびタンパク質マーカー |
| JP2015253708A Pending JP2016105097A (ja) | 2009-09-14 | 2015-12-25 | ニューロン損傷診断のためのマイクロｒｎａ、自己抗体およびタンパク質マーカー |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20130022982A1 (enExample) |
| EP (1) | EP2478360B1 (enExample) |
| JP (3) | JP5909447B2 (enExample) |
| AU (2) | AU2010291933B2 (enExample) |
| CA (1) | CA2774173A1 (enExample) |
| ES (1) | ES2687469T3 (enExample) |
| HU (1) | HUE040281T2 (enExample) |
| WO (1) | WO2011032155A2 (enExample) |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8492107B2 (en) | 2004-04-15 | 2013-07-23 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
| NO2324360T3 (enExample) | 2008-08-11 | 2018-06-30 | ||
| CA2766057A1 (en) * | 2009-06-19 | 2010-12-23 | Banyan Biomarkers, Inc. | Biomarker assay of neurological condition |
| US20170315136A9 (en) * | 2009-06-19 | 2017-11-02 | Banyan Biomarkers, Inc. | Biomarker assay of neurological condition |
| ES2687469T3 (es) | 2009-09-14 | 2018-10-25 | Banyan Biomarkers, Inc. | Marcadores autoanticuerpos para el diagnóstico de traumatismo craneoencefálico |
| WO2012045324A1 (en) * | 2010-10-07 | 2012-04-12 | Mediagnost Gesellschaft Fur Forschung Und Herstellung Von Diagnostika Gmbh | Method for detecting a parkinson's disease and test system |
| EP2628013B1 (en) | 2010-10-14 | 2019-06-12 | The Johns Hopkins University | Biomarkers of brain injury |
| DE102011011280A1 (de) * | 2011-02-15 | 2012-08-16 | Euroimmun Medizinische Labordiagnostika Ag | Diagnosekit sowie ein Verfahren zur Untersuchung einer menschlichen Patientenprobe auf das Vorhandensein von Neuromyelitis-optica-spezifischen Antikörpern |
| US20140302532A1 (en) | 2011-04-12 | 2014-10-09 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury |
| GB201111361D0 (en) * | 2011-07-04 | 2011-08-17 | Nordic Bioscience As | Biochemical markers for neurodegenerative conditions |
| WO2013024469A1 (en) * | 2011-08-16 | 2013-02-21 | Rosetta Genomics Ltd. | Methods and compositions for diagnosis of alzheimer's desease |
| WO2013138509A1 (en) | 2012-03-13 | 2013-09-19 | The Johns Hopkins University | Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration |
| US20150119273A1 (en) * | 2012-05-16 | 2015-04-30 | Trustees Of Boston University | Chronic Traumatic Encephalopathy in Blast-Exposed Individuals |
| KR20150036346A (ko) * | 2012-07-03 | 2015-04-07 | 워싱턴 유니버시티 | Tau에 대한 항체 |
| US20140073524A1 (en) * | 2012-09-07 | 2014-03-13 | Institute For Systems Biology | Markers and methods for detecting posttraumatic stress disorder (ptsd) |
| US9856532B2 (en) * | 2012-09-07 | 2018-01-02 | Institute For Systems Biology | Markers and methods for detecting posttraumatic stress disorder (PTSD) |
| EP3757226A3 (en) | 2013-07-17 | 2021-05-05 | The Johns Hopkins University | A multi-protein biomarker assay for brain injury detection and outcome |
| GB201319761D0 (en) * | 2013-11-08 | 2013-12-25 | Nordic Bioscience As | Biomarkers of disease progression |
| CN103656685B (zh) * | 2014-01-10 | 2016-01-13 | 厦门大学 | microRNA-219在制备抗癫痫药物中的应用 |
| WO2015134551A1 (en) * | 2014-03-03 | 2015-09-11 | Banyan Biomarkers, Inc. | Micro rna markers for diagnosis of a neurological condition |
| US9605315B2 (en) | 2014-03-26 | 2017-03-28 | The University Of Montana | Detection of traumatic brain injury |
| CA2943396A1 (en) * | 2014-04-07 | 2015-10-15 | Iron Horse Diagnostics, Inc. | Traumatic brain injury and neurodegenerative biomarkers, methods, and systems |
| CN106605146B (zh) * | 2014-04-08 | 2020-07-28 | 佛罗里达大学研究基金会有限公司 | 用于中枢神经系统的急性、亚急性和慢性创伤性损伤的蛋白质标志物 |
| WO2015160391A1 (en) * | 2014-04-15 | 2015-10-22 | The Government Of The United States, As Represented By The Secretary Of The Army, On Behalf Of Walter Reed Army Institute Of Research | Diagnosis and treatment of tauopathy and chronic traumatic encephalopathy |
| WO2015196191A1 (en) * | 2014-06-20 | 2015-12-23 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Microrna biomarkers for traumatic brain injury and methods of use thereof |
| CA2962593A1 (en) * | 2014-09-26 | 2016-03-31 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Microrna biomarkers for posttraumatic stress disorder and methods of use thereof |
| EP3702786A1 (en) * | 2014-10-06 | 2020-09-02 | Université de Genève | Markers and their use in brain injury |
| JP2018510359A (ja) * | 2015-02-05 | 2018-04-12 | イミューンアレイ ユーエスエイ インコーポレイテッド | 脳損傷または神経変性を診断するための方法および組成物 |
| WO2016205730A1 (en) * | 2015-06-18 | 2016-12-22 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Citrullinated proteins and their breakdown products as tbi biomarkers |
| CA2993989A1 (en) * | 2015-07-29 | 2017-02-02 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Microrna biomarkers for traumatic brain injury and methods of use thereof |
| US11053545B2 (en) | 2015-09-08 | 2021-07-06 | The Translational Genomics Research Institute | Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries |
| CA3042630A1 (en) * | 2015-11-18 | 2017-05-26 | Dignity Health | Methods of diagnosing epilepsy |
| GB201603967D0 (en) * | 2016-03-08 | 2016-04-20 | Univ Birmingham | Biomarkers of traumatic brain injury |
| JP6430680B2 (ja) * | 2016-04-28 | 2018-11-28 | 一般財団法人生産技術研究奨励会 | 神経細胞を培養する装置、神経細胞を培養する方法、培養された神経細胞、軸索束内のプロテインを解析及び同定する方法並びに神経細胞の使用方法 |
| WO2017193119A1 (en) * | 2016-05-06 | 2017-11-09 | Duke University | Methods and kits for diagnosing and treating nervous system disease or injury |
| EP3509646A4 (en) * | 2016-09-09 | 2020-06-17 | Mayo Foundation for Medical Education and Research | METHOD AND MATERIALS FOR IDENTIFYING AND TREATING AUTOIMMUNE GFAP ASTROCYTOPATHY |
| IT201600093825A1 (it) * | 2016-09-19 | 2018-03-19 | Fondazione St Italiano Tecnologia | Composizione farmaceutica di miRNA e suoi usi terapeutici. |
| WO2018081649A1 (en) | 2016-10-28 | 2018-05-03 | Banyan Biomarkers, Inc. | Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods |
| WO2018096049A1 (en) * | 2016-11-23 | 2018-05-31 | Randox Laboratories Ltd | Gfap derivatives for stroke diagnostics |
| EP3580355A4 (en) * | 2017-02-07 | 2020-12-16 | Bioregency, Inc. | S100BETA AND ITS ISOFORMS FOR THE DETECTION OF NEUROLOGICAL AFFECTIONS |
| SG11201907422RA (en) | 2017-02-17 | 2019-09-27 | Denali Therapeutics Inc | Anti-tau antibodies and methods of use thereof |
| JP7346300B2 (ja) | 2017-03-23 | 2023-09-19 | アボット・ラボラトリーズ | 早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼｌ１を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法 |
| JP7067800B2 (ja) * | 2017-04-12 | 2022-05-16 | 国立大学法人九州大学 | 神経障害性疼痛マーカー及びその使用 |
| CN110546513A (zh) | 2017-04-15 | 2019-12-06 | 雅培实验室 | 使用早期生物标记物帮助超急性诊断和确定人类受试者中的创伤性脑损伤的方法 |
| CN110603449A (zh) | 2017-04-28 | 2019-12-20 | 雅培实验室 | 用同一人受试者的至少两种样品的早期生物标记物帮助超急性诊断确定创伤性脑损伤的方法 |
| AU2018272054B2 (en) | 2017-05-25 | 2024-10-31 | Abbott Laboratories | Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers |
| US10849548B2 (en) | 2017-05-30 | 2020-12-01 | Abbott Laboratories | Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers |
| KR20200026834A (ko) | 2017-06-02 | 2020-03-11 | 더 존스 홉킨스 유니버시티 | 파킨슨병에 걸린 환자의 csf 중 par의 검출 |
| CN110998321A (zh) * | 2017-06-02 | 2020-04-10 | 约翰霍普金斯大学 | 帕金森氏症患者脑脊液中par的检测方法 |
| ES2993181T3 (en) * | 2017-06-19 | 2024-12-23 | St Johns Univ | Circulating serum microrna biomarkers and methods for determining the progression rate of parkinson's disease |
| CA3068041C (en) | 2017-07-03 | 2024-06-25 | Abbott Laboratories | Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood |
| EP3700556A2 (en) | 2017-10-25 | 2020-09-02 | Janssen Pharmaceuticals, Inc. | Compositions of phosphorylated tau peptides and uses thereof |
| JP6942036B2 (ja) * | 2017-11-30 | 2021-09-29 | 藤倉化成株式会社 | 脳梗塞の発症リスクを高感度に検出する体液抗体バイオマーカー |
| US11022617B2 (en) | 2017-12-09 | 2021-06-01 | Abbott Laboratories | Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) |
| CA3067055A1 (en) | 2017-12-09 | 2019-06-13 | Abbott Laboratories | Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1 |
| EP3732489B1 (en) | 2017-12-29 | 2025-10-22 | Abbott Laboratories | Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury |
| KR102026675B1 (ko) * | 2018-02-12 | 2019-09-30 | 강원대학교산학협력단 | miR-135a-5p 및 p62에 의한 알레르기 반응 조절 메커니즘 및 이의 이용 |
| EP4403923A3 (en) * | 2018-03-08 | 2024-11-27 | Meso Scale Technologies, LLC | Genetic marker and/or biomarkers for traumatic brain injury, and ultrasensitive assays for biomarkers of traumatic brain injury |
| JP6499342B2 (ja) * | 2018-03-19 | 2019-04-10 | 隆樹 日和佐 | 脳梗塞の診断マーカー |
| EP3784274A1 (en) * | 2018-04-27 | 2021-03-03 | Fondazione Ebri Rita Levi-Montalcini | Antibody directed against a tau-derived neurotoxic peptide and uses thereof |
| CN112585281A (zh) * | 2018-07-25 | 2021-03-30 | 斯纳利蒂克斯股份有限公司 | 用于阿尔茨海默氏病的小rna预测因子 |
| CN110824156B (zh) * | 2018-08-14 | 2023-08-11 | 欧蒙医学诊断（中国）有限公司 | 神经自身免疫疾病的诊断 |
| US20210270847A1 (en) * | 2018-08-17 | 2021-09-02 | University Of Florida Research Foundation, Incorporated | Protein and peptide biomarkers for traumatic injury to the central nervous system |
| CN113195740A (zh) * | 2018-10-17 | 2021-07-30 | 奥克斯纳健康系统公司 | 在脑内出血和蛛网膜下腔出血中的血浆和脑脊液miRNA生物标志物 |
| CN109266739A (zh) * | 2018-11-29 | 2019-01-25 | 成都仕康美生物科技有限公司 | 一种检测脑损伤的miRNA标志物、试剂盒、应用 |
| WO2020113271A1 (en) * | 2018-12-04 | 2020-06-11 | La Trobe University | Methods of diagnosing a disease state |
| EA202192203A1 (ru) | 2019-02-08 | 2021-10-20 | Ац Иммуне С.А. | СПОСОБ БЕЗОПАСНОГО ВВЕДЕНИЯ ВАКЦИНЫ ФОСФОРИЛИРОВАННОГО ПЕПТИДА Tau |
| MX2021009829A (es) * | 2019-02-14 | 2021-12-10 | Marker Diagnostics Uk Ltd | Biomarcadores salivales de lesion cerebral. |
| GB201909393D0 (en) * | 2019-06-28 | 2019-08-14 | Gen2 Neuroscience Ltd | Tau epitope and binding molecules |
| CN110551809A (zh) * | 2019-08-21 | 2019-12-10 | 昆明医科大学第一附属医院 | miR-124在脊髓损伤修复中的用途 |
| US11644463B2 (en) * | 2019-08-30 | 2023-05-09 | Euroimmun Medizinische Labordiagnostika Ag | Detection of an autoantibody |
| US20230250480A1 (en) * | 2020-07-09 | 2023-08-10 | University Of Florida Research Foundation, Incorporated | Biofluid-based protein and mirna biomarkers for neonatal hypoxic-ischemic encephalopathy |
| WO2022046614A1 (en) * | 2020-08-24 | 2022-03-03 | Marabio Systems, Inc. | Methods for reducing maternal autoantibodies |
| KR102357260B1 (ko) * | 2020-12-10 | 2022-02-08 | 주식회사 레피겐엠디 | 마이크로rna를 이용한 당뇨병성 신경병증의 예측 및 진단 방법 및 이를 위한 키트 |
| CN113238045B (zh) * | 2021-04-27 | 2021-12-28 | 南方医科大学南方医院 | Crmp2及抗crmp2抗体的应用 |
| KR102759445B1 (ko) * | 2021-11-16 | 2025-01-24 | 한국한의학연구원 | 치료에 따른 보행 장애 개선 판별용 바이오마커 및 이의 용도 |
| TWI853766B (zh) * | 2022-12-22 | 2024-08-21 | 國立臺灣大學 | 用於心跳停止病患頭部電腦斷層之灰白質比率自動計算方法 |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5707796A (en) | 1990-06-11 | 1998-01-13 | Nexstar Pharmaceuticals, Inc. | Method for selecting nucleic acids on the basis of structure |
| US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
| US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
| US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
| US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| EP0533838B1 (en) | 1990-06-11 | 1997-12-03 | NeXstar Pharmaceuticals, Inc. | Nucleic acid ligands |
| US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
| US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| AU2414092A (en) * | 1991-08-01 | 1993-03-02 | Paul H. Voorheis | Diagnostic method for alzheimer's disease |
| US5731410A (en) | 1994-11-28 | 1998-03-24 | University Of Utah Research Foundation | Peptide for blocking autoantibody-evoked activation of glutamate receptor type 3 (GLUR3) |
| EP1112500B1 (en) * | 1998-09-08 | 2004-09-22 | Innogenetics N.V. | Tau as a marker for early cns damage |
| US20020002270A1 (en) | 1999-06-16 | 2002-01-03 | Raymond P. Zinkowski | Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| US6589746B1 (en) * | 1999-10-21 | 2003-07-08 | University Of Cincinnati | Method of detecting axonally-derived protein tau in patients with traumatic CNS injury |
| WO2003016910A1 (en) | 2001-08-20 | 2003-02-27 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US20040203083A1 (en) | 2001-04-13 | 2004-10-14 | Biosite, Inc. | Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases |
| US20030199000A1 (en) | 2001-08-20 | 2003-10-23 | Valkirs Gunars E. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US20040253637A1 (en) | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| US7713705B2 (en) | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| US20020172676A1 (en) * | 2001-05-16 | 2002-11-21 | George Jackowski | Method of treatment of alzheimer's disease and device therefor |
| US7144708B2 (en) | 2001-06-25 | 2006-12-05 | The Cleveland Clinic Foundation | Markers of blood barrier disruption and methods of using same |
| WO2003032894A2 (en) * | 2001-10-12 | 2003-04-24 | Pfizer Products Inc. | Method of monitoring neuroprotective treatment |
| AU2003243563A1 (en) | 2002-06-12 | 2004-09-28 | The Cleveland Clinic Foundation | Markers of blood barrier permeability and methods of using same |
| AU2003270509B2 (en) | 2002-09-11 | 2009-03-26 | University Of Florida | Analyzing nerve cell damage |
| CA2511501A1 (en) | 2002-12-24 | 2004-07-15 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| EP2341350B1 (en) | 2003-09-20 | 2017-11-08 | Electrophoretics Limited | Diagnostic method for brain damage-related disorders based on detection of dj-1 |
| EP1519194A1 (en) | 2003-09-24 | 2005-03-30 | Roche Diagnostics GmbH | Use of gfap for identification of intracerebral hemorrhage |
| US20140303041A1 (en) | 2004-04-15 | 2014-10-09 | University Of Florida Research Foundation Inc. | In vitro diagnostic devices for nervous system injury and other neural disorders |
| JP4659025B2 (ja) | 2004-04-15 | 2011-03-30 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | 神経系傷害および他の神経障害についての生物マーカーとしての神経タンパク質 |
| US8492107B2 (en) | 2004-04-15 | 2013-07-23 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
| CA2578680C (en) * | 2004-04-15 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining |
| GB2428240A (en) * | 2005-07-14 | 2007-01-24 | Univ Gen Ve | Diagnostic method for brain damage-related disorders |
| WO2007046811A2 (en) | 2005-10-20 | 2007-04-26 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| JP5266459B2 (ja) | 2006-02-15 | 2013-08-21 | 国立大学法人三重大学 | 診断用組換えプロテオリポソームの作製法 |
| WO2007136617A2 (en) * | 2006-05-18 | 2007-11-29 | Walter Reed Army Institute Of Research (Wrair) | Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury |
| EP2024395A4 (en) | 2006-05-26 | 2009-07-01 | Biosite Inc | USE OF NATRIURETIC PEPTIDES AS DIAGNOSTIC AND PROGNOSTIC INDICATORS IN VASCULAR DISEASES |
| EP3115785A3 (en) | 2008-02-04 | 2017-02-22 | Banyan Biomarkers, Inc. | Process to diagnose or treat brain injury |
| EP2143735A1 (en) | 2008-07-10 | 2010-01-13 | Institut Pasteur | Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| US20140342381A1 (en) | 2008-08-11 | 2014-11-20 | Banyan Biomarkers, Inc. | Devices and methods for biomarker detection process and assay of neurological condition |
| NO2324360T3 (enExample) * | 2008-08-11 | 2018-06-30 | ||
| US20120094295A1 (en) | 2008-11-21 | 2012-04-19 | The Johns Hopkins University | Neurodegenerative disease diagnostic compositions and methods of use |
| US20170315136A9 (en) | 2009-06-19 | 2017-11-02 | Banyan Biomarkers, Inc. | Biomarker assay of neurological condition |
| CA2766057A1 (en) | 2009-06-19 | 2010-12-23 | Banyan Biomarkers, Inc. | Biomarker assay of neurological condition |
| WO2011011334A2 (en) | 2009-07-18 | 2011-01-27 | Banyan Biomarkers, Inc. | SYNERGISTIC BIOMARKER ASSAY OF NEUROLGICAL CONDITION USING S-100β |
| ES2687469T3 (es) | 2009-09-14 | 2018-10-25 | Banyan Biomarkers, Inc. | Marcadores autoanticuerpos para el diagnóstico de traumatismo craneoencefálico |
| EP2553466A4 (en) | 2010-04-01 | 2013-10-16 | Banyan Biomarkers Inc | MARKERS AND ASSAYS FOR DETECTING NEUROTOXICITY |
| WO2011160096A2 (en) | 2010-06-17 | 2011-12-22 | Banyan Biomarkers, Inc. | Glial fibrillary acidic protein, autoantigens and autoantibodies thereto as biomarkers of neural injury or neurological disorder or condition |
| AU2012308305B2 (en) | 2011-09-14 | 2017-11-23 | Banyan Biomarkers, Inc. | Processes and kits to detect and monitor for diagnostic biomarkers for post traumatic stress disorder (PTSD) and to differentiate between suicidal and non-suicidal form of the disorder |
| US20140024053A1 (en) | 2012-07-20 | 2014-01-23 | Banyan Biomarkers, Inc. | Methods, kits and devices for detecting bii-spectrin, and breakdown products thereof, as biomarkers for the diagnosis of neural injury |
| US20140275294A1 (en) | 2013-03-15 | 2014-09-18 | Banyan Biomarkers, Inc. | Devices and methods for biomarker detection process and assay of liver injury |
| US20150141528A1 (en) | 2013-05-31 | 2015-05-21 | Banyan Biomarkers, Inc. | Neural specific s100b for biomarker assays and devices for detection of a neurological condition |
-
2010
- 2010-09-14 ES ES10816275T patent/ES2687469T3/es active Active
- 2010-09-14 JP JP2012528991A patent/JP5909447B2/ja active Active
- 2010-09-14 WO PCT/US2010/048789 patent/WO2011032155A2/en not_active Ceased
- 2010-09-14 HU HUE10816275A patent/HUE040281T2/hu unknown
- 2010-09-14 AU AU2010291933A patent/AU2010291933B2/en not_active Expired - Fee Related
- 2010-09-14 EP EP10816275.1A patent/EP2478360B1/en not_active Revoked
- 2010-09-14 US US13/395,931 patent/US20130022982A1/en not_active Abandoned
- 2010-09-14 CA CA2774173A patent/CA2774173A1/en not_active Abandoned
-
2015
- 2015-12-25 JP JP2015253708A patent/JP2016105097A/ja active Pending
-
2016
- 2016-12-07 AU AU2016269481A patent/AU2016269481B2/en not_active Ceased
- 2016-12-27 US US15/391,755 patent/US10041959B2/en active Active
-
2017
- 2017-06-05 JP JP2017111070A patent/JP6469760B2/ja active Active
-
2018
- 2018-08-01 US US16/052,512 patent/US20190064188A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017181518A5 (enExample) | ||
| JP2016105097A5 (enExample) | ||
| US11389453B2 (en) | Compositions and methods for treating chemosensory dysfunction | |
| US8293489B2 (en) | Methods for detection of biological substances | |
| US9910049B2 (en) | Detection of misfolded amyloid beta protein | |
| US10989718B2 (en) | Detection of misfolded alpha synuclein protein | |
| JP2021505844A5 (enExample) | ||
| US7670849B2 (en) | Method for diagnosing insulin resistance from nasal secretions | |
| WO2011032155A3 (en) | Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury | |
| AU2018202468B2 (en) | Agents for influenza neutralization | |
| US20130137120A1 (en) | Amyloid b measurement method | |
| RU2015116674A (ru) | Способ диагностики или мониторинга почечной функции или диагностики почечной дисфункции | |
| TW202136297A (zh) | Tau蛋白病變及失智症相關疾病之判定藥及判定方法 | |
| US20250189543A1 (en) | Method for quantifying active orexin a | |
| JP2012513584A5 (enExample) | ||
| BR112013030646A2 (pt) | uso diagnóstico de pró-somatostatina | |
| US20250355002A1 (en) | Identification of tdp-43 cryptic exon-encoded neoepitopes as functional fluid biomarkers for alzheimer's disease and related dementia | |
| JP2009244225A (ja) | 脳炎の診断方法及び脳炎の診断システム | |
| Bach et al. | What autoantibodies tell us about the pathogenesis of Parkinson's disease. | |
| WO2012140148A3 (en) | Junction plakoglobin for diagnosis of cardiovascular diseases | |
| CA2837522A1 (en) | Biomarkers for autoimmune liver diseases and uses thereof | |
| JP2015503106A5 (enExample) | ||
| JP2020153832A (ja) | オートタキシン測定による神経障害性疼痛を検出する方法及び検出試薬 | |
| JP5682795B2 (ja) | Ａｐｐの局在の検出方法 | |
| BRAIN | AMPA/QUISQUALATE RECEPTOR CAPABLE |